WHITE PINE CAPITAL LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITE PINE CAPITAL LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$367,000
+32.5%
1,3380.0%0.13%
+31.3%
Q2 2018$277,000
-75.1%
1,338
-80.1%
0.10%
-75.9%
Q1 2018$1,112,000
+13.0%
6,733
-6.3%
0.41%
+13.9%
Q4 2017$984,000
+0.9%
7,183
+0.3%
0.36%
+17900.0%
Q3 2017$975,000
+8.0%
7,158
-3.8%
0.00%
-99.4%
Q2 2017$903,000
+13.2%
7,438
-1.3%
0.36%
+9.9%
Q1 2017$798,000
+4.0%
7,538
-0.2%
0.32%
-0.3%
Q4 2016$767,000
-0.5%
7,5500.0%0.32%
-1.2%
Q3 2016$771,000
-21.2%
7,550
-7.9%
0.33%
-20.1%
Q2 2016$978,000
-14.1%
8,200
-22.8%
0.41%
-15.4%
Q1 2016$1,138,000
-2.8%
10,625
-1.7%
0.49%
-6.0%
Q4 2015$1,171,000
+24.6%
10,805
-1.6%
0.52%
+18.8%
Q3 2015$940,000
-18.7%
10,980
-4.1%
0.44%
-11.9%
Q2 2015$1,156,000
-5.7%
11,455
-28.0%
0.50%
-0.4%
Q1 2015$1,226,000
+53.2%
15,905
+5.8%
0.50%
+84.8%
Q4 2014$800,000
+42.1%
15,030
+25.5%
0.27%
+40.1%
Q3 2014$563,000
-10.1%
11,975
+19.2%
0.19%
+68.4%
Q2 2014$626,000
-7.4%
10,0500.0%0.11%
-6.6%
Q1 2014$676,000
-54.3%
10,050
-64.3%
0.12%
-55.5%
Q4 2013$1,480,000
+13.5%
28,150
-6.6%
0.27%
+16.1%
Q3 2013$1,304,000
-32.0%
30,150
-41.1%
0.24%0.0%
Q2 2013$1,917,00051,2250.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders